Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention BIO International Convention 2026, the most common co-covered peer. Zhaoke Ophthalmology appears in 1 tracked Biotech story from August 7, 2026.
Last mentioned: Aug 7, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention BIO International Convention 2026, the most common co-covered peer. Zhaoke Ophthalmology appears in 1 tracked Biotech story from August 7, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Zhaoke Ophthalmology. Shared-story counts are live from our verified record — not editorial picks.
Zhaoke Ophthalmology Signs Deal
Zhaoke Ophthalmology announced a signed memorandum of understanding, marking a concrete commercial outcome from the convention.
Invest in San Diego Breakfast
The delegation attended the San Diego Regional Economic Development Corporation’s breakfast, connecting with one of the world’s top life sciences clusters.
BIO International Convention 2026 Kicks Off
The Hong Kong Pavilion opened, showcasing 41 entities in AI-enabled biotech, therapeutics, diagnostics, and pharmaceuticals.
Global Mixer Sessions Commence
Two mixer sessions at the Hong Kong Pavilion attracted over 150 attendees, with more than 40 Hong Kong exhibitors delivering rapid pitches.
Bio Nexus HK Networking Event
Hosted on the eve of the convention, the networking dinner and fireside chat drew more than 100 investors, founders, and senior decision-makers, setting the stage for partnerships.
Hong Kong sent its largest-ever biotech delegation—41 firms and 5 top-100 universities—to BIO 2026, focusing on AI-enabled biotech and securing a memorandum of understanding from Zhaoke Ophthalmology. The engagement underscores the city’s growing role as a bridge between Asian innovation and US life sciences.
Zhaoke Ophthalmology is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
